European Guidance for the Diagnosis and Management of Osteoporosis in Postmenopausal Women

Overview

Journal Osteoporos Int

Specialties Endocrinology
Orthopedics

Date 2018 Oct 17

PMID 30324412

Citations 637

Authors

J A Kanis

C Cooper

R Rizzoli

J-Y Reginster

Affiliations

Soon will be listed here.

Abstract

Introduction: The International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis published guidance for the diagnosis and management of osteoporosis in 2013. This manuscript updates these in a European setting.

Methods: Systematic reviews were updated.

Results: The following areas are reviewed: the role of bone mineral density measurement for the diagnosis of osteoporosis and assessment of fracture risk; general and pharmacological management of osteoporosis; monitoring of treatment; assessment of fracture risk; case-finding strategies; investigation of patients; health economics of treatment. The update includes new information on the evaluation of bone microstructure evaluation in facture risk assessment, the role of FRAX® and Fracture Liaison Services in secondary fracture prevention, long-term effects on fracture risk of dietary intakes, and increased fracture risk on stopping drug treatment.

Conclusions: A platform is provided on which specific guidelines can be developed for national use.

Citing Articles

Radiofrequency Echographic Multi Spectrometry-A Novel Tool in the Diagnosis of Osteoporosis and Prediction of Fragility Fractures: A Systematic Review.

Icatoiu E, Vladulescu-Trandafir A, Groseanu L, Berghea F, Cobilinschi C, Potcovaru C Diagnostics (Basel). 2025; 15(5).

PMID: 40075802 PMC: 11898608. DOI: 10.3390/diagnostics15050555.

The Relationship Between the Heterogeneity of Lumbar Vertebral Trabecular Bone Mineral Density Distribution and Osteoporotic Vertebral Fractures.

Wang Y, Ma D, Wang C, Zhang X, Tang M, Hu J Calcif Tissue Int. 2025; 116(1):49.

PMID: 40067443 DOI: 10.1007/s00223-025-01342-4.

Fractures in Hereditary Neuromuscular Disorders: Frequency, Risk Factors, and Implications.

Opsomer M, Iterbeke L, Borghs H, De Cuyper T, Dejaeger M, Dupont P Eur J Neurol. 2025; 32(3):e70099.

PMID: 40040345 PMC: 11880628. DOI: 10.1111/ene.70099.

Sequential and combination therapy with romosozumab.

Kobayakawa T J Bone Miner Metab. 2025; .

PMID: 40024934 DOI: 10.1007/s00774-025-01590-2.

Bone mineral density in patients using aromatase inhibitors: a clinical, nutritional, and quality of life assessment.

Souza A, Barra S, Rocha A, Bemquerer L, Oliveira S, Carvalho L Braz Oral Res. 2025; 39:e023.

PMID: 40008732 PMC: 11844819. DOI: 10.1590/1807-3107bor-2025.vol39.023.

References

Leslie W, Morin S, Lix L, Johansson H, Oden A, McCloskey E . Fracture risk assessment without bone density measurement in routine clinical practice. Osteoporos Int. 2011; 23(1):75-85. DOI: 10.1007/s00198-011-1747-2. View

Boonen S, Van Meirhaeghe J, Bastian L, Cummings S, Ranstam J, Tillman J . Balloon kyphoplasty for the treatment of acute vertebral compression fractures: 2-year results from a randomized trial. J Bone Miner Res. 2011; 26(7):1627-37. DOI: 10.1002/jbmr.364. View

Bolland M, Grey A, Reid I . Re: The calcium scare: what would Austin Bradford Hill have thought?. Osteoporos Int. 2011; 22(12):3079-80. DOI: 10.1007/s00198-011-1783-y. View

Kiel D, Magaziner J, Zimmerman S, Ball L, Barton B, Brown K . Efficacy of a hip protector to prevent hip fracture in nursing home residents: the HIP PRO randomized controlled trial. JAMA. 2007; 298(4):413-22. DOI: 10.1001/jama.298.4.413. View

Leslie W, Rubin M, Schwartz A, Kanis J . Type 2 diabetes and bone. J Bone Miner Res. 2012; 27(11):2231-7. DOI: 10.1002/jbmr.1759. View

Ellis A, Reginster J, Luo X, Bushmakin A, Williams R, Sutradhar S . Indirect comparison of bazedoxifene vs oral bisphosphonates for the prevention of vertebral fractures in postmenopausal osteoporotic women. Curr Med Res Opin. 2014; 30(8):1617-26. DOI: 10.1185/03007995.2014.908279. View

Johnell O, Kanis J . An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006; 17(12):1726-33. DOI: 10.1007/s00198-006-0172-4. View

Kanis J, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby A . International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res. 2002; 17(7):1237-44. DOI: 10.1359/jbmr.2002.17.7.1237. View

Leslie W, Lix L, Tsang J, Caetano P . Single-site vs multisite bone density measurement for fracture prediction. Arch Intern Med. 2007; 167(15):1641-7. DOI: 10.1001/archinte.167.15.1641. View

10.

Edmondson C, Schwartz E . Non-BMD DXA measurements of the hip. Bone. 2017; 104:73-83. DOI: 10.1016/j.bone.2017.03.050. View

11.

Ganda K, Puech M, Chen J, Speerin R, Bleasel J, Center J . Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int. 2012; 24(2):393-406. DOI: 10.1007/s00198-012-2090-y. View

12.

Hiligsmann M, Ben Sedrine W, Bruyere O, Evers S, Rabenda V, Reginster J . Cost-effectiveness of vitamin D and calcium supplementation in the treatment of elderly women and men with osteoporosis. Eur J Public Health. 2014; 25(1):20-5. DOI: 10.1093/eurpub/cku119. View

13.

Adler R, Fuleihan G, Bauer D, Camacho P, Clarke B, Clines G . Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2015; 31(1):16-35. PMC: 4906542. DOI: 10.1002/jbmr.2708. View

14.

Rabenda V, Bruyere O, Reginster J . Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression. Osteoporos Int. 2010; 22(3):893-901. DOI: 10.1007/s00198-010-1469-x. View

15.

Martineau P, Leslie W, Johansson H, Oden A, McCloskey E, Hans D . Clinical Utility of Using Lumbar Spine Trabecular Bone Score to Adjust Fracture Probability: The Manitoba BMD Cohort. J Bone Miner Res. 2017; 32(7):1568-1574. DOI: 10.1002/jbmr.3124. View

16.

Lippuner K, Johansson H, Borgstrom F, Kanis J, Rizzoli R . Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland. Osteoporos Int. 2012; 23(11):2579-89. DOI: 10.1007/s00198-011-1869-6. View

17.

Lewiecki E, Watts N, McClung M, Petak S, Bachrach L, Shepherd J . Official positions of the international society for clinical densitometry. J Clin Endocrinol Metab. 2004; 89(8):3651-5. DOI: 10.1210/jc.2004-0124. View

18.

Ethgen O, Hiligsmann M, Burlet N, Reginster J . Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fractures. Arch Public Health. 2015; 73:48. PMC: 4677432. DOI: 10.1186/s13690-015-0099-3. View

19.

Cosman F, de Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S . Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014; 25(10):2359-81. PMC: 4176573. DOI: 10.1007/s00198-014-2794-2. View

20.

Leal J, Gray A, Hawley S, Prieto-Alhambra D, Delmestri A, Arden N . Cost-Effectiveness of Orthogeriatric and Fracture Liaison Service Models of Care for Hip Fracture Patients: A Population-Based Study. J Bone Miner Res. 2016; 32(2):203-211. PMC: 5321497. DOI: 10.1002/jbmr.2995. View